EDGE
Book a demo

All Updates

Filter
This week:
Funding
PsyBio Therapeutics plans CAD 1 million in private placement
Psychedelic Medicine
Yesterday
Earnings/results
Numinus provides business update for FY2022; reports strong revenue growth with Novamind acquisition
Psychedelic Medicine
Nov 30
Funding
Revive Therapeutics plans up to USD 5 million in private placement
Psychedelic Medicine
Nov 30
Earnings/results
PsyBio Therapeutics provides business update for Q3 2022; plans to expand patent portfolio to 29 in Q4
Psychedelic Medicine
Nov 29
Earnings/results
Braxia Scientific provides business update for Q2 FY2023; focuses on clinic expansion and telemedicine
Psychedelic Medicine
Nov 29
Funding
Mydecine files prospectus for USD 4.5 million; closes first tranche
Psychedelic Medicine
Nov 28
Last week:
M&A
PanGenomic Health acquires Mindleap Health
Psychedelic Medicine
Nov 21
Funding
Awakn Life Sciences raises USD 1.9 million in private placement
Psychedelic Medicine
Nov 17
Earnings/results
Mydecine provides clinical and business updates for Q3 2022
Psychedelic Medicine
Nov 15
Listing
Funding
Clearmind Medicine plans USD 7.5 million underwritten public offering; lists on Nasdaq Capital Market
Psychedelic Medicine
Nov 14
Earnings/results
Cybin Inc. provides clinical and business updates for Q2 2022
Psychedelic Medicine
Nov 14
Earnings/results
Reunion Neuroscience Inc provides clinical and business updates for Q2 2022
Psychedelic Medicine
Nov 14
Earnings/results
MindMed provides financial and business update for Q3 2022
Psychedelic Medicine
Nov 10
Earnings/results
Filament Health provides financial and business update for Q3 2022
Psychedelic Medicine
Nov 10
Earnings/results
ATAI Life Sciences provides financial and business update for Q3 2022
Psychedelic Medicine
Nov 10
Regulation/policy
Industry news
Colorado legalizes the use of psychedelic mushrooms
Psychedelic Medicine
Nov 9
Earnings/results
Compass Pathways provides financial and business update for Q3 2022
Psychedelic Medicine
Nov 3
Partnerships
Funding
Lusaris Therapeutics raises USD 60 million in a Series A funding round; launches from stealth
Psychedelic Medicine
Nov 2
Partnerships
PharmaTher partners with Case Western Reserve University to develop ketamine for Rett syndrome
Psychedelic Medicine
Nov 1
M&A
Beckley Psytech acquires Eleusis to bolster pipeline and team
Psychedelic Medicine
Oct 24
Earnings/results
Small Pharma expands patent portfolio with three new granted patents
Psychedelic Medicine
Oct 14
Earnings/results
PharmaTher releases FY2022 results; expects clinical trial approvals in 2023
Psychedelic Medicine
Sep 29
Listing
Funding
Silo Pharma raises USD 5 million in public offering; uplists to Nasdaq
Psychedelic Medicine
Sep 28
M&A
Silo Wellness acquires Dyscovry Science to enter the pharma space
Psychedelic Medicine
Sep 27
Funding
MindMed announces underwritten public offering
Psychedelic Medicine
Sep 27
M&A
Lobe Sciences incorporates Australian subsidiary to conduct clinical trials
Psychedelic Medicine
Sep 23
Industry news
Colorado to conduct psychedelic decriminalization ballot
Psychedelic Medicine
Sep 20
Earnings/results
Awakn Life Sciences reports 34% QoQ revenue growth; announces private placement to raise CAD 3 million
Psychedelic Medicine
Sep 15
Earnings/results
Wellbeing Digital Sciences reports Q4 results; pushes financial year end to October
Psychedelic Medicine
Sep 15
Funding
Lobe Sciences raises USD 1.5 million from Cantheon Capital for Australian clinical trials
Psychedelic Medicine
Sep 1
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.